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ABSTRACT

INTRODUCTION
RNA interference (RNAi) is a naturally occurring mechanism for messenger RNA (mRNA) degradation in
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One critical step in RNA interference (RNAi)
experiments is to design small interfering RNAs
(siRNAs) that can greatly reduce the expression
of the target transcripts, but not of other unintended
targets. Although various statistical and computational approaches have been attempted, this
remains a challenge facing RNAi researchers.
Here, we present a new experimentally validated
method for siRNA design. By analyzing public
siRNA data and focusing on hyperfunctional
siRNAs, we identified a set of sequence features
as potency selection criteria to build an siRNA
design algorithm with support vector machines.
Additional bioinformatics filters were also included
in the algorithm to increase RNAi specificity by
reducing potential sequence cross-hybridization
or microRNA-like effects. Independent validation
experiments were performed, which indicated that
the newly designed siRNAs have significantly
improved performance, and worked effectively
even at low concentrations. Furthermore, our cellbased studies demonstrated that the siRNA offtarget effects were significantly reduced when the
siRNAs were delivered into cells at the 3 nM concentration compared to 30 nM. Thus, the capability of
our new design program to select highly potent
siRNAs also renders increased RNAi specificity
because these siRNAs can be used at a much
lower concentration. The siRNA design web server
is available at http://www5.appliedbiosystems.com/
tools/siDesign/.

animals and plants (1–3). RNAi has been widely used to
study gene functions by targeted cleavage of mRNA
transcripts. Because of its convenience as well as its low
cost, RNAi-based gene expression knockdown has
become one of the most rapidly adopted molecular
biology techniques in recent years. One popular way to
initiate RNAi-induced mRNA degradation is through
the introduction of chemically synthesized small
interfering RNAs (siRNAs) into cells.
Over the past few years, there have been extensive
studies on designing siRNAs with high mRNA knockdown eﬃciency (4). Randomly selected siRNA sequences
were screened to identify features that are relevant
to siRNA potency. One feature, for example, is that the
50 -end of the siRNA guide strand should have lower
thermodynamic stability compared to the 30 -end
because the guide strand of an siRNA duplex must be
preferentially taken up by the RNA-induced silencing
complex for eﬀective mRNA degradation (5,6).
Additionally, the base composition at certain positions
in an siRNA also plays an important role in determining
the siRNA potency (7,8). A high propensity of secondary
structure in the guide siRNA strand may prevent its
binding to the mRNA target site and reduce siRNA
silencing eﬃcacy (9,10). In addition, the availability of
the mRNA target binding sites by the RNA-induced
silencing complex may also be important for siRNA
potency (11–13).
Multiple statistical and computational models have
been proposed in recent years to design functional
siRNA. For example, Reynolds et al. (7) have developed
an siRNA design model by empirically summarizing
relevant selection features. More recently, by analyzing
over 2000 randomly selected siRNA sequences, Huesken
et al. (8) have developed a neural network model to
predict siRNA potency. There have been other siRNA
prediction models using various machine learning
techniques (14–21). Despite intense research eﬀorts on
siRNA design, there is still signiﬁcant room for algorithmic improvement by optimizing the computational
feature selection and modeling process. More importantly,
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few of the existing design algorithms have been experimentally validated, which limits their practical applications.
Here, we present an experimentally validated siRNA
design algorithm built with support vector machines
(SVMs) to predict hyperfunctional siRNAs. This algorithm employs a new feature selection process, and
combines both feature ﬁltering and modeling processes.
Comparative analysis indicates that our new algorithm
has signiﬁcantly improved performance over the existing
algorithm trained with the same data set. Also importantly, our new algorithm has been rigorously validated
experimentally for its ability to select hyperfunctional
siRNAs that function eﬀectively even at low concentrations. The high eﬃcacy of these siRNAs at low
concentrations makes it possible to reduce RNAi oﬀtarget eﬀects by using a much reduced amount of
siRNAs, as demonstrated in our cell-based screening
studies.

Data retrieval
An siRNA data set was analyzed in our study for algorithm training and testing (8). This data set contains
the sequences and knockdown data for over 2000
siRNA sequences randomly selected from the transcript
sequence positions. The RefSeq sequences were
downloaded from the NCBI ftp site (22).
Computational tools and data analysis
The SVM package LIBSVM was used to construct our
siRNA prediction models (http://www.csie.ntu.edu
.tw/cjlin/libsvm/). For SVM analysis, a Radial Basis
Function was used for kernel transformation. Grid
search was performed to identify the optimal parameters
(C = 128 and g = 0.002) for the Radial Basis Function
kernel using the recommended protocol by LIBSVM.
In the Huesken study, the performance of BIOPREDsi
was evaluated using an independent data set [Figure 2c
in ref. (8)]. In our algorithm comparison analysis, this
testing data set was used to evaluate the performance of
BIOPREDsi by determining the percentage of selected
testing siRNAs that were at least 80 or 90% as eﬃcient
as the positive control. Only the siRNAs with the
highest BIOPREDsi scores (top 10% among all testing
siRNAs) were selected to represent the performance of
BIOPREDsi.
RNA secondary structure stability, represented by
the G value, was calculated with RNAFold (23).
Statistical computing was performed with the R package
(http://www.r-project.org/). The statistical signiﬁcance
(P-value) for the selected biochemical features was
calculated with Student’s t-test, chi-square test or
hypergeometric test.
The web server for siRNA design using our new design
algorithm is available at http://www5.appliedbiosystems
.com/tools/siDesign/

Two validation experiments were included in this study.
For the ﬁrst validation experiment, all siRNAs were
synthesized by Ambion (Austin, TX, USA). HeLa cells
were reverse transfected with siRNAs in triplicate using
siPORTTM NeoFXTM Transfection Agent. Forty-eight
hours post-transfection, RNA was isolated using the
MagMAX-96 Total RNA Isolation Kit, then reverse
transcribed using the RETROscriptÕ First Strand cDNA
Synthesis Kit (Ambion). Real-time polymerase chain
reaction (PCR) was performed on an Applied Biosystems
7900HT Fast Real-Time PCR System using TaqManÕ
Gene Expression Assays, followed by relative quantitation
using the Ct method with 18S ribosomal RNA (rRNA)
as the endogenous control. Silencer Negative Control
#1 siRNA-treated cells were included for knockdown
eﬃciency analysis. Knockdown results were represented
as the average of median percent mRNA remaining
compared to Silencer Negative Control #1 siRNA-treated
samples from two duplicated experiments.
For the second validation experiment, the performance of siRNA products designed using three diﬀerent
algorithms was directly compared. Ten gene targets were
tested side by side for mRNA knockdown eﬃcacy in HeLa
cells. One hundred siRNAs selected for these genes were
ordered from Ambion (designed with our new algorithm),
Qiagen [designed with the BIOPREDsi algorithm (8)]
or Dharmacon [designed with the Reynolds algorithm
(7)]. All siRNAs were transfected at 3 and 30 nM
ﬁnal concentrations using LipofectamineTM RNAiMax
siRNA transfection agent (Invitrogen) according to the
manufacturer’s recommendations. After 48 h, mRNA
levels were analyzed using the TaqManÕ Gene
Expression Cell-to-CtTM kit and the TaqManÕ gene
expression assays (Applied Biosystems).
Cell-based mitosis assays
siRNAs were transfected in the U2-OS osteosarcoma cell
line at both 3 and 30 nM concentrations. Mitotic cells
were identiﬁed using immunoﬂuorescence detection of
phosphorylated histone H3 as the antigen marker.
Immunoﬂuorescence signals were collected using automated image acquisition of assay plates on the
ImageXpress Micro automated ﬂuorescence microscope
(Molecular Devices, Toronto, Canada). Images were
analyzed using the MetaMorph image analysis software
package. Nine positions in each 96-well sample were collected, and the data were averaged across three biological replicates and compared to similarly treated negative
siRNA control samples (scrambled non-targeting siRNA).
Following imaging analysis, data are evaluated according
to the following protocol: (i) Index calculation: for each
site within a well, the number of mitotic cells was
normalized against the total number of nuclei and the
area of non-cell background was subtracted from the
total image area to calculate the area occupied by cells,
and then normalized against the number of nuclei. (ii)
Sample well average calculation: the average of all sites
within a well was calculated. Additionally, all sites of all
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negative control wells per plate were averaged. (iii)
Normalization: samples in each plate were normalized
against the average of negative siRNA control wells. (iv)
Triplicate average calculation: the average of the plate
triplicates was calculated for each treatment and readout.
RESULTS
Identiﬁcation of sequence features relevant to siRNA
eﬃcacy

Base composition. The base composition of each of the
21 positions in an siRNA guide strand sequence was
analyzed and the signiﬁcant patterns were identiﬁed by
the hypergeometric test (Supplementary Table S1). The
analysis results in general agreed well with the previous
studies (7,8). For example, for potent siRNA sequences,
the ﬁrst position of the guide strand was overwhelmingly
A or U, and A was overrepresented at position 10.
Strand bias. Previous studies demonstrate the importance
of diﬀerential end stability in predicting functional
siRNAs using small sets of siRNAs (5,6). Here, we
analyzed the Huesken data set and the same conclusion
was observed. In general, the guide strands of highly
potent siRNAs had signiﬁcantly less stable 50 -ends
compared to the guide strands of less potent or nonfunctional siRNAs (P = 1.9E-06, Student’s t-test).
GC content and siRNA binding stability. siRNAs with
very high GC content are less likely to be functional (7).
This conclusion was conﬁrmed by analyzing the Huesken
data set (P = 4.0E-13, Student’s t-test). Thermodynamic

properties may play an important role in siRNA functionality. One important thermodynamic feature is the
stability of target transcript binding by the siRNA.
This is an overlapping feature to the GC content feature
because siRNAs with high GC content tend to bind tightly
to the target sites. However, the binding free energy was
calculated with the nearest neighbor method (24), and
thus was considered as a more accurate measurement of
binding stability than the GC content. A large number of
non-functional siRNAs bind extremely tightly to their
target sites (P = 3.8E-14, Student’s t-test).
The secondary structures of the siRNAs and their target
sites. An siRNA is less likely to be functional if its
mRNA target site is inaccessible due to secondary structure formation (11). The local secondary structures for
81 nucleotides around the target sites were calculated
with RNAFold (23). Compared to non-functional
siRNAs, highly potent siRNAs tend to target regions
with less potential for stable secondary structures
(P = 1.2E-11, Student’s t-test). We also considered the
secondary structures of the siRNAs. Our analysis
showed that none of the functional siRNAs have highly
stable secondary structures (P = 6.2E-12, Student’s t-test).
One previous study suggested that a functional siRNA is
more likely to have an accessible 30 -end in its guide strand
so that the guide strand can easily enter into the RNAinduced silencing complex (25). Thus, in our study we also
calculated the end accessibility of the siRNAs (i.e. to
examine whether the 30 -end is freely exposed) as represented by binary values.
An SVM model to predict siRNA potency by integrating
multiple sequence features
An SVM-based siRNA design algorithm was developed
by integrating the sequence features described above.
The program workﬂow is presented in Figure 1. The
LIBSVM package was used for algorithm training and
testing.
Similar to the feature selection process, only the
most and the least potent siRNAs were used to build
Experimental data
Feature extraction
Biological features
Applying oligo filters
Pre-qualified siRNAs
Data transformation and scaling
Data for SVM training
SVM training and optimization
SVM classifier

Validation with
independent data

siRNA prediction

Figure 1. The workﬂow for functional siRNA prediction with a new
design algorithm.
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Huesken et al. (8) have analyzed over 2000 randomly
selected siRNA sequences for their target knockdown eﬃciency as determined by ﬂuorescence reporter assays.
Based on this training data set, a neural network model
was developed, which was shown to have a robust performance in selecting siRNAs with high eﬃcacy (8). This
same data set was analyzed in our study for the development of a new improved siRNA selection algorithm.
As a major deviation from the existing algorithms, we
did not use all random siRNA sequences in the data set
for the identiﬁcation of features relevant to siRNA
potency. Instead, we compared the 200 most potent
siRNAs and the 200 least potent siRNAs to identify
features that characterized the hyperfunctional siRNAs.
Our design goal was to conﬁdently pick the most potent
siRNAs while rejecting other siRNAs including the ones
with moderate knockdown activity. Since SVM is a binary
classiﬁcation process, we reasoned that by comparing the
‘best’ and the ‘worst’ siRNA sequences directly, relevant
predictive features for hyperfunctional siRNAs can be
more sensitively identiﬁed. In contrast, if all siRNA
sequences in the data set were used, the selection process
would be biased toward the siRNAs with moderate
eﬃcacy because these siRNAs signiﬁcantly outnumbered
the hyperfunctional siRNAs. Below is a summary of the
selection features that were signiﬁcantly associated with
hyperfunctional siRNAs. The complete set of features
used for SVM training is listed in Supplementary Table S2.
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Table 1. Prediction features that were ﬁltered before the SVM
modeling process
Filtered features

Value range

50 -end base
GC content (%)
Strand bias (G) (kcal/mol)
Duplex binding (G) (kcal/mol)
siRNA folding (G) (kcal/mol)
Target site folding (G) (kcal/mol)

A or U
25–55
3.5 to 6.0
 39.0
 5.0
 30.0

Free energy (G) calculation for duplex binding and strand bias was
performed with the nearest neighbor method (24). Secondary structure
stability was measured by the free energy (G) calculated with
RNAfold (23).

Figure 2. Evaluation of the predictive power of the design model.
(A) Precision–recall analysis to evaluate the prediction performance.
The ‘X’ label represents the prediction performance using the threshold
SVM prediction score (0.8). (B) The score distributions for high-eﬃcacy
and low-eﬃcacy siRNAs. High eﬃcacy was deﬁned to be at least 90%
as eﬃcient as the positive control. All other siRNAs in the data set are
deﬁned as low-eﬃcacy siRNAs.

On average, the fraction of correctly predicted potent
siRNAs in the testing set was 77.0%, which was much
higher than the fraction of all potent siRNAs in the
testing set (29.5%).
Precision–recall curves were drawn to evaluate the
prediction performance of our new prediction model.
Precision–recall curves are commonly used in machine
learning to address binary decision problems, and they
are a sensitive way to examine the prediction precision
(correctly predicted positives divided by total predicted
positives) in relation to the recall rate (correctly predicted
positives divided by total actual positive training samples).
In most cases for siRNA design, only a few functional
siRNAs need to be selected for each gene target.
Therefore, precision–recall analysis is an especially useful
technique to examine the prediction performance for the
few top siRNA candidates. As shown in Figure 2A, the
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SVM models. Although there were 2430 siRNA sequences
in the original data set, only 300 sequences with >95 or
<65% knockdown eﬃciencies were used for model
training. After manually examining the incorrect predictions by the SVM, some of the failures were identiﬁed
to be related to a few extreme values in several training
features (e.g. extremely stable secondary structure of the
siRNA). This posed a challenge to SVM modeling, as
these extreme values did not seem to be properly
modeled by the SVM due to their rare frequency in the
training data. To address this issue, the data set was ﬁrst
ﬁltered to remove sequences with extreme feature values
before the SVM training and testing process. These
sequence ﬁlters are listed in Table 1. Most functional
siRNAs were retained after excluding the siRNAs with
extreme feature values. Therefore, the improvement of
the prediction performance did not lead to a signiﬁcant
increase of the false negative rate. For example, one
important ﬁlter is the exclusion of sequences with C or
G at the 50 -end. Most functional siRNAs (85%) contain
A or T at this position. Thus, by excluding sequences with
C or G at the 50 -end, half of the 2430 siRNAs from the
original data set were excluded from our SVM analysis,
while most functional siRNAs were still kept. Because
the 50 -end base feature was so signiﬁcant at identifying
potent sequences, it became a dominating factor in the
SVM model and overshadowed other less obvious but
important features. Thus, by focusing on a subset of
siRNA sequences all starting with A or T, other relevant
features were more likely to be properly represented in the
SVM model. In developing our ﬁnal design algorithm,
training data ﬁltration was performed before SVM
modeling. The combination of both the ﬁltering step and
the SVM modeling process led to improved prediction
performance, resulting in 77% prediction speciﬁcity as
described in detail below.
The Huesken data set was randomly partitioned, with
90% of the siRNAs as the training data and 10% of the
siRNAs as the testing data. The data partition process was
repeated three times so that three distinct training and
testing groups were generated. Three SVM models were
generated based on the three training groups. Each data
partition led to an SVM model with a similar performance
when applied to the testing data. A testing siRNA was
considered to be potent if it was at least 90% eﬃcient
in knockdown as compared to the positive control.
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Table 2. Performance comparison of diﬀerent siRNA design algorithms

New SVM model (%)
BIOPREDsi (%)
Random siRNA (%)

80% of control

90% of control

95
69
46

77
47
30

Two knockdown thresholds, 80 or 90% eﬃcacy of the positive control,
were chosen in the algorithm comparative analysis. The percentages of
the siRNAs that rendered at least the threshold knockdown eﬃcacy
were presented here. For the BIOPREDsi algorithm, the prediction
performance was estimated by analyzing the siRNAs with the highest
prediction scores (top 10%, see ‘Materials and Methods’ for details).

Bioinformatics ﬁlters for siRNA speciﬁcity
The mechanisms for siRNA oﬀ-targeting are not well
understood at present. There might be multiple
mechanisms that lead to unintended siRNA knockdown.
It is possible that oﬀ-targeting would occur if there is signiﬁcant sequence cross-hybridization between an siRNA
oligo and its unintended target transcript. To address this
concern, multiple sequence-based ﬁlters were implemented
in our new design algorithm to reduce potential sequence
cross-reactivity. It is known that low sequence complexity
contributes to cross-hybridization (26). Thus, transcript

Experimental validation of siRNA eﬃcacy
During the SVM modeling process, the performance of
our siRNA selection algorithm was computationally
validated using published data sets. However, the best
way to determine true model performance is to test the
predictions with new independent experimental data. To
this end, a double-blind randomized experiment was
designed to evaluate model performance. Similar design
strategies are widely used in clinical trials for unbiased
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precision rate is 70–80% when the recall rate is <40%.
The calculated P-values by the SVM model were used as
the algorithm prediction scores. The score distributions
for the functional and non-functional siRNAs were
compared to evaluate the diﬀerentiating power of the
scoring system (Figure 2B). High-eﬃcacy siRNAs were
deﬁned to be at least 90% as eﬃcient as the positive
control, and all other siRNAs were deﬁned to be
low-eﬃcacy siRNAs. The high-eﬃcacy siRNA scores
were signiﬁcantly separated from the low-eﬃcacy siRNA
scores, with a major mode at 0.8 (Figure 2B). Therefore,
the score 0.8 was chosen as the cutoﬀ threshold for the
prediction of functional siRNAs.
The new model performance was compared to the
BIOPREDsi algorithm (8). The BIOPREDsi algorithm
(a neural network model) was developed by analyzing
the same training data set as used in our study. A
testing data set was also presented to evaluate the performance of BIOPREDsi in ref. (8); however, the details of
this data set are not publicly available. Thus, the
algorithms cannot be directly compared using the same
testing data set. In our comparative analysis, the performance of our model was evaluated with three randomly
partitioned testing data sets as described earlier. These
training data sets had not been used in the model
training process and thus represent independent data.
The average SVM model performance for predicting the
knockdown eﬃcacy of the three testing data sets was presented in Table 2. Our new model was shown to have
signiﬁcantly improved performance over the Huesken
algorithm in predicting hyperfunctional siRNAs that
were at least 90% as eﬃcient as the positive control
(77 and 47% correct predictions for the new model and
BIOPREDsi, respectively).

sequences were evaluated for sequence complexity,
and low-complexity regions were identiﬁed by the
DUST program and avoided when selecting siRNA
sequences (27).
Mismatches can reduce oligo priming stability
and sometimes even a single mismatch within a long
stretch of the nucleotide duplex could have a signiﬁcant
destabilizing eﬀect (28,29). Thus, continuous base pairing
contributes signiﬁcantly to nucleotide duplex stability,
potentially leading to cross-hybridization. Expression
proﬁling studies also suggest that contiguous base
pairing contributes to non-speciﬁc siRNA targeting (30).
In our siRNA sequence selection process, we employed an
algorithm that we previously developed to quickly identify
stretches of 15 contiguous bases that match perfectly to
unintended transcripts in the transcriptome (31). In brief,
redundant 15-mer sequences were identiﬁed using a
computational hashing technique with two 10-mer
sequences as the basic hash keys. Every possible 15-mer
in an siRNA sequence was tested against all transcript
sequences in the transcriptome. An siRNA candidate
would be excluded from further consideration if a repetitive 15-mer was present in its sequence. As a further step
to reduce cross-reactivity, BLAST search was performed
against all known sequences in the transcriptome and an
siRNA candidate would be discarded if the BLAST score
was >30 [threshold value adopted based on our previous
study (31)].
Another possible mechanism for unintended siRNA oﬀtargeting could be the so-called ‘microRNA eﬀect’, i.e. an
siRNA could behave like a microRNA (miRNA) and
target multiple unintended transcripts (32,33). The
miRNA targeting process is not well understood to date.
However, many studies indicate that the miRNA seed
regions (positions 2–8) are usually required to match
perfectly to the target transcript. Thus, if an siRNA
behaves like a miRNA, its seed sequence typically pairs
perfectly to the non-speciﬁc target transcripts. As a seed
sequence only contains seven nucleotides, it is not possible
to select such a short sequence that is unique in the
whole transcriptome. To partly address this potential
‘miRNA-like’ eﬀect, we focused on comparing the
siRNA seed sequences with the seeds from all known
miRNAs. We hypothesized that if an siRNA shares the
same seed sequence with an endogenous miRNA, then this
siRNA would have similar functions to the miRNA by
targeting a similar group of transcripts. To this end, the
seed sequence of an siRNA candidate was examined and
an siRNA candidate would be discarded if its seed
sequence was shared by any known miRNA.

e152 Nucleic Acids Research, 2009, Vol. 37, No. 22

performance at both siRNA concentrations compared to
the other algorithms (P = 4.1E-05 and 0.0001, respectively, when compared with the Reynolds algorithm at 3
or 30 nM with Student’s t-tests; P = 0.004 and 0.01,
respectively, when compared with BIOPREDsi at 3 or
30 nM). Interestingly, none of the 10 siRNAs designed
for LDLR (including three from our new algorithm)
could reduce the mRNA expression to <30% at either 3
or 30 nM, indicating that a small number of genes might
be recalcitrant to RNAi-based gene expression
knockdown.
The eﬀect of siRNA concentration on gene knockdown
The eﬃcacy of the siRNAs selected by the new model was
further evaluated at ﬁve siRNA concentrations. For this
experiment, 73 siRNAs were designed to target 10 genes.
These siRNAs eﬀectively suppressed the expression of the
target transcripts when introduced at high concentrations
as shown in Figure 4A. Interestingly, the knockdown
potency was essentially unchanged when the siRNA concentration was decreased to 3 nM. The siRNA potency
decreased dramatically when the concentration was
further decreased to 0.03 nM. Thus, RNAi experiments
can be performed using a few namomolar of our newly
designed siRNAs without loss of knockdown eﬃciency.
Reduced oﬀ-target eﬀects with hyperfunctional siRNAs
at a low concentration
Since the siRNAs designed by our new algorithm rendered
ample gene knockdown even at low concentrations
(Figure 4A), we further characterized these siRNAs to
determine whether a decreased siRNA concentration
leads to signiﬁcantly reduced oﬀ-target eﬀects.
High-content cell microscopy assays were performed to
evaluate the impact of siRNA concentration on oﬀ-target
eﬀects. Fourteen siRNAs designed for three genes
(FDFT1, LDLR and SC5DL) were tested in this study.
These genes are mainly involved in cholesterol biosynthesis. FDFT1, LDLR and SC5DL have been extensively
characterized by various researchers and have not been
observed to have direct impacts on cell cycle control or
cellular mitosis. Thus, we hypothesized that any impacts
on cellular mitosis that were observed following transfection of siRNA designed to target one of these genes
could be the consequence of oﬀ-targeting. The mitosis
screening assay data were normalized to three negative
control siRNAs included in each plate. As positive
controls, 11 siRNAs were also included in the screening
experiment targeting genes WEE1 and PLK1, which are
known to be directly involved in the mitosis process
(34,35). As expected, the knockdown of either WEE1 or
PLK1 led to a signiﬁcant increase in the number of cells in
mitosis (Figure 4B). This cellular phenotype from the
positive control siRNAs was not aﬀected by the amount
of siRNAs introduced into the cells, indicating that the
positive control siRNAs worked eﬀectively at 3 nM. As
to the 14 siRNAs targeting genes unrelated to mitosis,
they behaved similarly to the negative control siRNAs
or mock transfection controls (no RNA duplex added)
when transfected at 3 nM. Little change in the number
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evaluation of competing treatment plans. Our new design
algorithm was compared to two other methods. One
method was based on a linear statistical model after
analyzing an in-house training data set, and had been
used to design genome-wide SilencerÕ siRNA products
at Ambion; the other method selected the siRNAs from
random positions in the transcript sequences using a
software random function.
To reduce potential variations from gene-speciﬁc
eﬀects, we selected 14 genes covering a wide expression
spectrum in HeLa cells. Ten siRNAs for each gene
(three from the new model, three from the previous algorithm and four from randomly selected positions) were
evaluated at two diﬀerent concentrations, 3 and 30 nM.
To reduce potential experimental bias, the identity of
all these siRNAs was blinded from the researchers performing the validation experiments, including the siRNA
synthesis, transfection, and reverse transcription (RT) and
real-time PCR validation of the remaining mRNA expression level. The siRNA identity was only revealed at the
ﬁnal data analysis stage. To further reduce the experimental variation, all 140 siRNAs were synthesized in one
batch. Each siRNA was transfected in triplicate into the
cells and real-time RT–PCR was performed in duplicate
for each transfection. The entire validation experiment
was repeated twice on diﬀerent days. Thus, the eﬃcacy
of each siRNA was evaluated using 12 knockdown
measurements. The siRNAs were tested sequentially
according to the Random Index, which randomly determined the order of the siRNAs from the three algorithms
for each gene (Supplementary Table S3). The siRNA
sequences included in this validation experiment as well
as the knockdown eﬃcacy at 3 and 30 nM are summarized
in Supplementary Table S3. The 3 nM siRNA transfection
result is also presented in Figure 3A. A similar result was
obtained for the 30 nM siRNA transfection experiment.
Compared to the randomly designed siRNAs, the algorithm used to design SilencerÕ siRNAs was a major
improvement at picking functional siRNAs. More than
80% of the siRNAs picked by this algorithm reduced the
mRNA level by at least 80% at both 30 and 3 nM concentrations, which was in agreement with our previous observations. More interestingly, siRNAs designed with our new
model rendered even higher eﬃcacy. All 42 siRNAs
selected by the new model led to at least 80% reduction
of gene expression at both 30 and 3 nM concentrations.
Most of these siRNAs reduced the gene expression level
by >90% even at a low concentration (3 nM).
To further validate the performance of our new design
algorithm, a separate RNAi knockdown experiment was
performed to directly compare our newly designed
siRNAs with the siRNAs designed with two widely used
algorithms. In this experiment, 100 siRNAs designed for
10 genes were compared. Ten siRNAs for each gene,
including three designed by the new algorithm, three by
BIOPREDsi (8) and four by the Reynolds algorithm (7),
were analyzed for gene knockdown eﬃcacy at two
concentrations, 30 and 3 nM. The gene IDs and knockdown data are summarized in Supplementary Table S4.
As shown in Figure 3B and C, comparative analysis indicates that our new algorithm had signiﬁcantly improved
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Figure 3. Experimental validation of the new design algorithm. (A) Three siRNA design algorithms were compared in this experiment. Fourteen
genes were selected. For each gene, three siRNAs were picked by the new algorithm, three were picked by our previous algorithm and four were
picked by a random selection process. The remaining mRNA expression level was normalized to the negative control siRNA. All siRNAs were
transfected into HeLa cells at 3 nM in triplicate in a double-blind randomized experiment for testing the knockdown eﬃciency. The siRNAs from
each algorithm were sorted by their knockdown eﬃciency. (B and C) A second validation experiment to compare three widely used design
algorithms. siRNAs for 10 genes were designed with three algorithms. For each gene, three siRNAs were picked by the new algorithm, three
were picked by the BIOPREDsi algorithm and four were picked by the Reynolds algorithm. The remaining mRNA expression level was normalized
to the negative control siRNA. All siRNAs were transfected into HeLa cells either at 3 nM (B) or 30 nM (C) concentrations.

of mitotic cells was observed at this siRNA concentration.
In contrast, when present at a higher concentration
(30 nM), three of these siRNAs led to measurable
cellular mitosis phenotype, resulting in an increased
sample variability as measured by the SEM readings presented in Figure 4B (7.5 and 36.6 for 3 and 30 nM
siRNAs, respectively).
DISCUSSION
Techniques to evaluate the performance of siRNA
design algorithms
Correlation analysis and Receiver Operator Characteristic
(ROC) analysis are two popular approaches in machine

learning studies. However, both analyses have major
limitations when applied to siRNA design. For siRNA
design, usually only a few functional siRNAs need to be
selected for each gene from potentially hundreds of
siRNA candidates. A typical correlation analysis is to calculate the correlation coeﬃcients for all the siRNAs in the
sample space in relation to their knockdown eﬃciency.
Although it is interesting to use a design algorithm
to identify many siRNAs with moderate activity, it is
much more important practically to identify a few
hyperfunctional siRNAs with high precision. Therefore,
the prediction precision is a more important measurement
than the correlation coeﬃcient. Another issue in siRNA
design is that the vast majority of random siRNAs are not
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The capability of our new design algorithm for picking
hyperfunctional siRNAs with high accuracy has important implications to address the siRNA speciﬁcity issue.
One major issue in RNAi research is that many
unintended genes may also be targeted by an siRNA,
leading to widespread oﬀ-target eﬀects. The siRNA oﬀtarget eﬀect is one of the most challenging issues facing
RNAi researchers (4,30,32,36). To date, bioinformatics
design has failed to identify siRNA sequences that
would speciﬁcally target the genes of interest. Although
multiple speciﬁcity ﬁlters were implemented in our new
algorithm, the oﬀ-target issue is not likely to be
completely addressed by bioinformatics design alone.
One possible experimental approach to reduce the oﬀtarget eﬀects is to use much reduced amounts of siRNAs
for gene knockdown. Unfortunately, the knockdown
eﬃciency would decrease drastically at low siRNA
concentrations for most commercially available siRNA
products. At present, most manufacturers recommend
using 30–100 nM siRNA in RNAi experiments, which
inevitably leads to signiﬁcant oﬀ-target eﬀects. The high
eﬃcacy of our newly designed siRNAs oﬀers a unique
opportunity to address this issue experimentally. Our validation results indicate that eﬀective gene expression
knockdown can be achieved with a small amount of
siRNA. Thus, by decreasing the siRNA concentration,
the oﬀ-target eﬀects could be signiﬁcantly reduced as
demonstrated in our cell-based mitosis assays.
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Figure 4. Dose eﬀect on siRNA eﬃcacy and speciﬁcity.
(A) Experimental evaluation of the siRNA potency at diﬀerent concentrations. Seventy-three siRNAs targeting 10 genes were analyzed. Each
siRNA was transfected into HeLa cells at ﬁve concentrations, 0.03, 0.3,
3, 30 and 100 nM. The siRNA knockdown readings at each concentration were averaged and presented in the graph. The error bars represent
the standard error of the mean. (B) Cell-based mitosis assays to
evaluate the siRNA oﬀ-target eﬀects. Fourteen newly designed
siRNAs, targeting three genes unrelated to mitosis, were analyzed.
Each siRNA was transfected at both 3 and 30 nM, and potential
unintended eﬀects on mitosis were determined. Eleven siRNAs targeting WEE1 and PLK1 were included as positive controls. The data were
normalized to three negative control siRNAs. In the mock control
transfection experiment, no RNA duplex was added.

functional, and thus the data set is highly skewed toward
many non-functional sequences. As a result, the false
positive rate is very low in most cases even though the
absolute number of false positives may be unacceptably
high. In the ROC analysis, this observation is translated
into a steep curve with the ROC area close to 1 in most
cases. Thus, the ROC curves do not have much differentiating power at comparing diﬀerent algorithms for
the selection of only a few top candidates. Considering
these potential limitations, we adopted a new strategy
to evaluate siRNA prediction accuracy by performing
precision–recall analysis. Precision–recall curves are
commonly used in machine learning, and they are especially suitable for studies with a large percentage of
negative samples.
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Supplementary Data are available at NAR Online.
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